נאופרו 8 מ"ג / 24 שעות

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ROTIGOTINE 8 MG / 24 HOUR

MAH:

CTS LTD

ATC_code:

N04BC09

pharmaceutical_form:

PATCHES

administration_route:

TRANSDERMAL

manufactured_by:

UCB MANUFACTURING IRELAND LTD

therapeutic_group:

ROTIGOTINE

therapeutic_indication:

Neupro is indicated for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease as monotherapy (i.e. without levodopa) or in combination with levodopa, i.e. over the course of the disease, through the late stages when the effect of levodopa wears off or becomes inconsistent and fluctuations of the therapeutic effect occur (end of dose or "on-off" fluctuations).

authorization_date:

2012-09-01